182 related articles for article (PubMed ID: 22761786)
1. Proteolytic processing of ErbB4 in breast cancer.
Hollmén M; Liu P; Kurppa K; Wildiers H; Reinvall I; Vandorpe T; Smeets A; Deraedt K; Vahlberg T; Joensuu H; Leahy DJ; Schöffski P; Elenius K
PLoS One; 2012; 7(6):e39413. PubMed ID: 22761786
[TBL] [Abstract][Full Text] [Related]
2. Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms.
Hollmén M; Määttä JA; Bald L; Sliwkowski MX; Elenius K
Oncogene; 2009 Mar; 28(10):1309-19. PubMed ID: 19151766
[TBL] [Abstract][Full Text] [Related]
3. The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.
Kiuchi T; Ortiz-Zapater E; Monypenny J; Matthews DR; Nguyen LK; Barbeau J; Coban O; Lawler K; Burford B; Rolfe DJ; de Rinaldis E; Dafou D; Simpson MA; Woodman N; Pinder S; Gillett CE; Devauges V; Poland SP; Fruhwirth G; Marra P; Boersma YL; Plückthun A; Gullick WJ; Yarden Y; Santis G; Winn M; Kholodenko BN; Martin-Fernandez ML; Parker P; Tutt A; Ameer-Beg SM; Ng T
Sci Signal; 2014 Aug; 7(339):ra78. PubMed ID: 25140053
[TBL] [Abstract][Full Text] [Related]
4. Removal of cell surface heparan sulfate increases TACE activity and cleavage of ErbB4 receptor.
Määttä JA; Olli K; Henttinen T; Tuittila MT; Elenius K; Salmivirta M
BMC Cell Biol; 2009 Jan; 10():5. PubMed ID: 19171023
[TBL] [Abstract][Full Text] [Related]
5. Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4.
Lee HJ; Jung KM; Huang YZ; Bennett LB; Lee JS; Mei L; Kim TW
J Biol Chem; 2002 Feb; 277(8):6318-23. PubMed ID: 11741961
[TBL] [Abstract][Full Text] [Related]
6. Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.
Hutcheson IR; Goddard L; Barrow D; McClelland RA; Francies HE; Knowlden JM; Nicholson RI; Gee JM
Breast Cancer Res; 2011 Mar; 13(2):R29. PubMed ID: 21396094
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
Määttä JA; Sundvall M; Junttila TT; Peri L; Laine VJ; Isola J; Egeblad M; Elenius K
Mol Biol Cell; 2006 Jan; 17(1):67-79. PubMed ID: 16251361
[TBL] [Abstract][Full Text] [Related]
8. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.
Muraoka-Cook RS; Feng SM; Strunk KE; Earp HS
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):235-46. PubMed ID: 18437540
[TBL] [Abstract][Full Text] [Related]
9. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.
Vidal GA; Naresh A; Marrero L; Jones FE
J Biol Chem; 2005 May; 280(20):19777-83. PubMed ID: 15746097
[TBL] [Abstract][Full Text] [Related]
10. Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis.
Lopez-Font I; Sogorb-Esteve A; Javier-Torrent M; Brinkmalm G; Herrando-Grabulosa M; García-Lareu B; Turon-Sans J; Rojas-García R; Lleó A; Saura CA; Zetterberg H; Blennow K; Bosch A; Navarro X; Sáez-Valero J
Neurobiol Dis; 2019 Apr; 124():428-438. PubMed ID: 30594809
[TBL] [Abstract][Full Text] [Related]
11. Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling.
Paatero I; Jokilammi A; Heikkinen PT; Iljin K; Kallioniemi OP; Jones FE; Jaakkola PM; Elenius K
J Biol Chem; 2012 Mar; 287(13):9659-9671. PubMed ID: 22308027
[TBL] [Abstract][Full Text] [Related]
12. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.
Junttila TT; Sundvall M; Lundin M; Lundin J; Tanner M; Härkönen P; Joensuu H; Isola J; Elenius K
Cancer Res; 2005 Feb; 65(4):1384-93. PubMed ID: 15735025
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation regulates nuclear accumulation and signaling activity of the soluble intracellular domain of the ErbB4 receptor tyrosine kinase.
Knittle AM; Helkkula M; Johnson MS; Sundvall M; Elenius K
J Biol Chem; 2017 Dec; 292(48):19890-19904. PubMed ID: 28974580
[TBL] [Abstract][Full Text] [Related]
14. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells.
Zhu Y; Sullivan LL; Nair SS; Williams CC; Pandey AK; Marrero L; Vadlamudi RK; Jones FE
Cancer Res; 2006 Aug; 66(16):7991-8. PubMed ID: 16912174
[TBL] [Abstract][Full Text] [Related]
15. Role of ErbB4 in breast cancer.
Sundvall M; Iljin K; Kilpinen S; Sara H; Kallioniemi OP; Elenius K
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):259-68. PubMed ID: 18454307
[TBL] [Abstract][Full Text] [Related]
16. Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.
Molina MA; Codony-Servat J; Albanell J; Rojo F; Arribas J; Baselga J
Cancer Res; 2001 Jun; 61(12):4744-9. PubMed ID: 11406546
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
Haskins JW; Nguyen DX; Stern DF
Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-induced upregulation of Sftpb requires transcriptional control of neuregulin receptor ErbB4 in mouse lung type II epithelial cells.
Zscheppang K; Konrad M; Zischka M; Huhn V; Dammann CE
Biochim Biophys Acta; 2011 Oct; 1813(10):1717-27. PubMed ID: 21777626
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo.
Hsiao HC; Fan X; Jordan RE; Zhang N; An Z
Breast Cancer Res; 2018 Jun; 20(1):43. PubMed ID: 29859099
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.
Pitfield SE; Bryant I; Penington DJ; Park G; Riese DJ
Oncol Res; 2006; 16(4):179-93. PubMed ID: 17120616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
